Skip to content
Research/Metabolic Glp1/Exenatide

Exenatide

compound

preliminary evidencePublic

First FDA-approved GLP-1 RA. Derived from exendin-4. Available as twice-daily (Byetta) and weekly (Bydureon) formulations. Brand names: Byetta, Bydureon.

Category: Metabolic Glp1·Updated 5/20/2026
OverviewScienceClinicalSafetyPapersProtocolsOutcomes

Exenatide

First FDA-approved GLP-1 RA. Derived from exendin-4. Available as twice-daily (Byetta) and weekly (Bydureon) formulations. Brand names: Byetta, Bydureon.

ScienceComing soon
ClinicalComing soon
SafetyComing soon
PapersComing soon
ProtocolsComing soon
OutcomesComing soon